Executives On The Move
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: Three New CEOs Among This Week's Changes
Recent moves in the industry include new chief executive officers at Medisca, Anthos Therapeutics and Systimmune.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Executives On The Move: Three New CMOs And CFOs Among This Week's Changes
Recent moves in the industry include C-suite shuffles at PureTech Health and Traws Pharma, plus Xencor gets a new chief financial officer.
Executives On The Move: Hookipa Hooks Development Head From Evotec
Latest moves in biopharma leadership include Mark Winderlich becoming chief development officer at Hookipa Pharma and Dianne Hol leaving AstraZeneca to join Lundbeck, where she becomes EVP people and organization.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Bayer’s New Pharma Leader To Spearhead Growth From US
The troubled conglomerate is accelerating its moves to streamline its business, with the creation of a more customer- and US-focused pharma division.
Executives On The Move: New Hires At Everest Medicines, Arvinas, Fulcrum Therapeutics And More
Recent executive changes in the industry include seven new chief medical officers, and new chief commercial officers at Adaptimmune Therapeutics and Syndax Pharmaceuticals.
Executives On The Move: Changes At The Top At Aileron, KalVista And More
Recent moves in the industry include new chief medical officers at Rigel Pharmaceuticals and FibroGen, while Aileron Therapeutics and KalVista get new CEOs.
Executives On The Move: New CEOs At Nicox, Maxion Therapeutics And Fore Biotherapeutics
Other recent moves in the industry include 10 new chief financial officers, while Mithra Pharmaceuticals gets two co-chief executives officers.
Executives On The Move: Joseph Papa Joins Emergent BioSolutions As CEO Among Other Industry Moves
Recent moves within the industry include changes at the top for Ocular Therapeutix and Rayzebio, plus a new CEO for Bellicum Pharmaceuticals.
Executives On The Move: Changes At The Top At Ocuphire Pharma, YS Biopharma And More
Recent executive moves in the industry include new CEOs at Latigo Biotherapeutics and YS Biopharma Co, plus new directors at Cingulate.
AbbVie Stays On Script With Michael As Next CEO
As previously indicated, AbbVie will go with an internal candidate, president and COO Robert Michael, to succeed Richard Gonzalez as CEO. The company has recently positioned Michael prominently.
Executives On The Move: Grifols, TYK Medicines And Terns Pharmaceuticals Announce Changes
Recent C-suite moves in the industry include a new CEO for Grifols and changes at the top at Aligos Therapeutics and Cytophage Technologies.
Exscientia Focus Firmly On Pipeline After CEO Exit Scandal
The sacking of CEO Andrew Hopkins over inappropriate relationships with two employees has cast a cloud over the high-profile AI biotech.
Executives On The Move: 18 New CFOs As Five Companies Welcome New CEOs
Recent moves in the industry include new chief financial officers at 17 firms, while there are C-suite moves at Madrigal Pharmaceuticals, ACADIA Pharmaceuticals and BMS buy, Mirati Therapeutics.
Executives On The Move: New Directors At BeiGene, Mirati Therapeutics And Elevation Oncology
Recent industry appointments include new directors at Orchard Therapeutics, BeiGene and Mirati Therapeutics, among others.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.